45.03USD-2.62%Mkt Cap: 2.60B USDP/E: —Last update: 2026-06-01
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. It offers Qelbree…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap2.60B USD
Enterprise Value2.34B USD
Revenue (TTM)776.83M USD
Gross Profit644.39M USD
Net Income (TTM)-38.55M USD
Revenue/Share13.65 USD
Last Price45.03 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees778
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS8684591089
Valuation
P/E (Trailing)—
P/E (Forward)10.58
PEG—
EV/EBITDA19.06
EV/Revenue3.01
P/S3.45
P/B2.50
EPS (TTM)-0.51
EPS (Forward)4.37
52W Range
30.8349% of range59.68
52W High59.68 USD
52W Low30.83 USD
Profitability
Gross Margin89.63%
Oper. Margin-3.58%
EBITDA Margin15.79%
Profit Margin-5.36%
ROE-3.63%
ROA-2.65%
Growth
Revenue Growth38.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF47.33M USD
CapEx (TTM)1.34M USD
FCF Margin17.07%
FCF Yield5.10%
Net Debt-343.34M USD
Net Debt/EBITDA-2.80
Balance Sheet
Debt/Equity0.04
Current Ratio1.96
Quick Ratio1.51
Book Value/Sh18.48 USD
Cash/Share6.620 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)62.83 USD
Target Range55.00 USD – 66.00 USD
# Analysts6
Ownership
Shares Out.58.04M
Float52.12M
Insiders4.46%
Institutions103.79%
Short Interest
Short Ratio6.6d
Short % Float10.01%
Short % Out.8.15%
Shares Short4.73M
Short (prev mo.)4.73M
Technical
SMA 5049.65 (-9.3%)
SMA 20048.94 (-8.0%)
Beta0.57
S&P 52W Chg27.70%
Avg Vol (30d)643.05K
Avg Vol (10d)580.52K
Technical Indicators
RSI (14)38.0
MACD-0.7877
MACD Signal-0.4762
MACD Hist.-0.3115
BB Upper52.60 USD
BB Middle49.19 USD
BB Lower45.77 USD
BB Width13.88%
ATR (14)1.808 USD
Vol Ratio (20d)0.23x